Brain markers and brain stimulation for preventing postpartum depression
Part of Mental health, Women’s health & pregnancy clinical trials.
This study looks at whether brain scans and electrical signals can predict who might get postpartum depression, and tests a non-invasive brain stimulation treatment called TMS to see if it helps. Participating may give you early support and access to a treatment that could reduce your risk of depression after childbirth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a woman between 18 and 45 years old.
- If you're pregnant, you need to be at least 32 weeks along with a single baby.
- You may qualify if you're currently experiencing mild to moderate depression (Beck Depression Inventory score 14 or higher).
- You may also qualify if you're pregnant but not depressed, to serve as a comparison.
- You should not have any serious health conditions or complications with this pregnancy.
- You should not have a history of severe mental illness (like schizophrenia or bipolar disorder).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether repetitive transcranial magnetic stimulation (rTMS), a non-invasive treatment that uses magnetic pulses to stimulate brain areas involved in mood, can help women with depression during pregnancy or within the first year after giving birth. It aims to see if this treatment is safe and effective for peripartum depression.
This trial studies an intensive form of noninvasive brain stimulation (treatments given through the scalp) for postpartum depression. It aims to reduce depression symptoms and improve wellbeing in people who are at least 18 and have moderate symptoms.
This study tests a one-time, non-invasive brain stimulation treatment (using a mild electrical current) to see if it can improve depression symptoms in pregnant people. It aims to offer a new option that may be safer during pregnancy than some medications.
This trial tests a faster form of TMS (brain stimulation) for people with depression who are pregnant (14-34 weeks) or within one year of giving birth. It aims to see if the treatment is safe and well-tolerated.
This study uses brain imaging to guide a noninvasive treatment called transcranial magnetic stimulation (TMS) for people with depression. It aims to see if tailoring the stimulation to each person's brain can improve symptoms.
This trial tests a special type of TMS (brain stimulation) called SAINT for severe depression that started around childbirth. It may help new mothers who are still within a year postpartum and have not found relief from other treatments.
Hear when a new Depression, Postpartum trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.